ClinConnect ClinConnect Logo
Search / Trial NCT02931162

The Effects of Moxibustion on Ulcerative Colitis

Launched by SHANGHAI INSTITUTE OF ACUPUNCTURE, MOXIBUSTION AND MERIDIAN · Oct 11, 2016

Trial Information

Current as of June 25, 2025

Completed

Keywords

ClinConnect Summary

A total of 60 patients with UC were randomly divided into the following 2 groups: a) Herb-partition moxibustion (Treatment Group) and b) Sham herb-partition moxibustion (Control Group). All patients in the trial will be treated with moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. MRI will be used to observe the changes on brain structure and function in patients with UC, and further research on the characteristics of the brain nerve response of these patients with herb-partition moxibustion. In addition, tissue morphology and molecular biology tests will be c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Meet the diagnosis of UC
  • Mayo ≤10
  • Patients do not receive any medicine, or if they are receiving medicine, it should be aminosalicylates and/or prednisone (dose ≤15mg and have taken at least 1 month), and must kept the same dose as before throughout the trial;
  • Patients should have not received antibiotic, biologicals within 3 months prior to entering the study;
  • Signing a written informed consent.
  • Exclusion Criteria:
  • Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system, psychotic or any other serious diseases;
  • Pregnancy or lactation;
  • The psychiatric patients;
  • Current or prior history of neurosurgery, head injury, cerebrovascular insult, or brain trauma involving loss of consciousness;
  • Learning disability;
  • Claustrophobia;
  • Presence of metallic implants in the body;

About Shanghai Institute Of Acupuncture, Moxibustion And Meridian

The Shanghai Institute of Acupuncture, Moxibustion and Meridian is a leading research organization dedicated to advancing the field of traditional Chinese medicine through rigorous scientific inquiry. With a strong focus on acupuncture and moxibustion techniques, the institute aims to explore and validate the efficacy and mechanisms of these therapies in various clinical settings. Committed to fostering innovation and excellence, the institute collaborates with healthcare professionals and academic institutions to conduct clinical trials and promote evidence-based practices. Through its work, the Shanghai Institute strives to enhance patient care and contribute to the global understanding of integrative medicine.

Locations

Shanghai, Xuhui, China

Patients applied

0 patients applied

Trial Officials

Huangan Wu, Doctor

Study Director

Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai University of Traditional Chinese Medicine.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials